This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pierre Fabre Medicament. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Juliette Trepreau: Innovator in Cancer Treatment
Introduction
Juliette Trepreau is a prominent inventor based in Saint Julien en Genevois, France. She has made significant contributions to the field of cancer treatment through her innovative work in immunocytokines. Her dedication to advancing medical science has led to the development of groundbreaking therapies aimed at improving patient outcomes.
Latest Patents
Juliette Trepreau holds a patent for her invention titled "Immunocytokines for the treatment of cancer." This patent describes new immunocytokines that are useful for treating cancer. The fusion proteins consist of an antibody or an antigen-binding fragment fused to a cleavable peptide linker and a cytokine or its functional fragments. The methods of treatment using these immunocytokines are also disclosed in her patent.
Career Highlights
Juliette Trepreau is associated with Pierre Fabre Medicament, where she continues to work on innovative solutions for cancer treatment. Her research and development efforts have positioned her as a key figure in the pharmaceutical industry, particularly in the area of oncology.
Collaborations
Juliette has collaborated with notable professionals in her field, including Jean-François Haeuw and Peter Lowe. These collaborations have further enhanced her research and contributed to the advancement of cancer therapies.
Conclusion
Juliette Trepreau's work in developing immunocytokines represents a significant advancement in cancer treatment. Her innovative approach and dedication to research continue to inspire progress in the medical field.